MNG
BIIB icon

Manning & Napier Group’s Biogen BIIB Stock Holding History

Manning & Napier Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-178,560
Closed -$63.1M – 333
2018
Q3 		$63.1M Sell
178,560
-38,930
-18% -$13.4M 0.62% 49
2018
Q2 		$63.1M Sell
217,490
-172,760
-44% -$48.6M 0.62% 47
2018
Q1 		$107M Sell
390,250
-16,403
-4% -$5.09M 1.05% 34
2017
Q4 		$130M Buy
+406,653
New +$130M 1.16% 29

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Manning & Napier Group's BIIB Position: Q4 2018 in Review

Manning & Napier Group sold out of Biogen (BIIB) in Q4 2018, closing a stake of 178,560 shares — an estimated $63.1M sold.

Manning & Napier Group first reported a position in BIIB in Q4 2017 and held it in 4 quarters. The position peaked at $130M in Q4 2017. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Manning & Napier Group reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Manning & Napier Group sold 178,560 Biogen shares in Q4 2018, an estimated $63.1M.
  • Manning & Napier Group first reported a position in Biogen in Q4 2017 and held it in 4 quarters.
  • Manning & Napier Group's Biogen position peaked at $130M in Q4 2017.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Manning & Napier Group's 13F filing for Q4 2018, filed 24 Jan 2019.